Skip To Main Content
Yinghui Zhang on Muck Rack

Yinghui Zhang

As seen in: Wiley Online Library, PLOS ONE, Frontiers, Frontiers in Immunology, Frontiers in Public Health, MDPI, Taylor & Francis Online, BMC Biotechnology, Journal of Translational Medicine, Royal Society of Chemistry and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinghui

Contact Yinghui, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Eculizumab in rapidly progressive glomerulonephritis: a case-series report

|
By Xueting Li, Yinghui Zhang, Ben Ke
| Frontiers in Immunology
Abstract Objective: To describe the clinical outcomes and safety profile of eculizumab as adjunctive therapy in a case series of patients with rapidly progressive glomerulonephritis (RPGN) due to anti-glomerular basement membrane (GBM) disease and anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). Methods: We reported 7 patients with AAV and 5 patients with anti-GBM disease who presented to our center between March 2025 and January 2026.
Open in Who Shared Issue with article?

Does baseline proteinuria affect the efficacy of obinutuzumab in patients with primary membranous nephropathy and minimal change disease? a single-center retrospective study

|
By Xueting Li, Yinghui Zhang, Ben Ke
| Frontiers
Abstract Background: Primary membranous nephropathy (PMN) and minimal change disease (MCD) are common causes of nephrotic syndrome in adults and represent the two diseases in which anti-CD20 monoclonal antibodies are most widely used. Previous studies have demonstrated that the clinical efficacy of rituximab (RTX) is influenced by the baseline level of proteinuria. Obinutuzumab is a novel anti-CD20 monoclonal antibody with superior efficacy and safety to RTX.
Open in Who Shared Issue with article?

A Leaf Area Index dataset retrieved by benchmark-driven machine learning framework from Chinese Fengyun-3B VIRR data

|
By Yinghui Zhang, Yonghong Liu, Jiakai You
| Taylor & Francis Online
?Mathematical formulae have been encoded as MathML and are displayed in this HTML version using MathJax in order to improve their display. Uncheck the box to turn MathJax off. This feature requires Javascript. Click on a formula to zoom. ABSTRACT Leaf Area Index (LAI) serves as a key biophysical parameter for characterizing vegetation canopy structure and ecosystem functions.
Open in Who Shared Issue with article?
See all 39 licensed articles (43 Total)